Financial results - PHARMAPLUS SRL

Financial Summary - Pharmaplus Srl
Unique identification code: 14924168
Registration number: J2002000538330
Nace: 4773
Sales - Ron
15.435.607
Net Profit - Ron
319.734
Employees
88
Open Account
Company Pharmaplus Srl with Fiscal Code 14924168 recorded a turnover of 2024 of 15.435.607, with a net profit of 319.734 and having an average number of employees of 88. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmaplus Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 2.765.072 3.207.370 3.670.578 4.054.919 4.558.395 5.595.068 6.533.623 9.178.645 11.613.266 15.435.607
Total Income - EUR 2.785.199 3.281.802 3.778.182 4.056.668 4.587.403 5.619.783 6.554.226 9.185.142 11.643.347 15.456.141
Total Expenses - EUR 2.485.477 3.024.898 3.460.966 3.683.815 4.211.336 5.090.184 6.028.704 8.572.269 11.108.406 15.069.137
Gross Profit/Loss - EUR 299.721 256.904 317.215 372.853 376.068 529.600 525.522 612.872 534.940 387.004
Net Profit/Loss - EUR 259.324 216.412 254.600 309.475 313.045 461.033 456.789 524.578 449.650 319.734
Employees 31 38 42 41 45 44 49 59 71 88
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 33.7%, from 11.613.266 euro in the year 2023, to 15.435.607 euro in 2024. The Net Profit decreased by -127.403 euro, from 449.650 euro in 2023, to 319.734 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmaplus Srl

Rating financiar

Financial Rating -
PHARMAPLUS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmaplus Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmaplus Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmaplus Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmaplus Srl - CUI 14924168

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 794.063 792.611 723.784 858.651 816.693 784.714 1.103.476 1.113.673 1.809.962 2.193.524
Current Assets 762.241 862.136 1.078.643 1.457.639 1.514.742 2.072.823 2.306.890 3.456.446 4.167.056 5.520.970
Inventories 495.000 612.263 788.986 1.041.239 1.091.551 1.205.005 1.471.423 1.841.584 2.860.234 3.700.956
Receivables 237.688 119.287 267.346 399.562 416.121 683.939 723.238 1.566.704 1.253.763 1.317.054
Cash 29.553 130.586 22.311 16.838 7.070 183.879 112.229 48.157 53.058 502.961
Shareholders Funds 596.558 439.469 686.632 725.636 856.044 1.056.901 808.948 596.504 729.032 1.167.932
Social Capital 22.497 22.268 21.891 21.489 21.073 20.674 20.215 20.278 222.379 422.170
Debts 959.496 1.217.605 1.118.907 1.591.917 1.480.563 1.807.009 2.609.590 3.984.850 5.245.657 6.553.745
Income in Advance 1.802 1.326 853 395 0 0 0 0 10.628 9.484
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 5.520.970 euro in 2024 which includes Inventories of 3.700.956 euro, Receivables of 1.317.054 euro and cash availability of 502.961 euro.
The company's Equity was valued at 1.167.932 euro, while total Liabilities amounted to 6.553.745 euro. Equity increased by 442.974 euro, from 729.032 euro in 2023, to 1.167.932 in 2024. The Debt Ratio was 84.8% in the year 2024.

Risk Reports Prices

Reviews - Pharmaplus Srl

Comments - Pharmaplus Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.